Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Lung Neoplasms 4Multiple Pulmonary Nodules 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Solitary Pulmonary Nodule 1Smoking Cessation 1Small Cell Lung Carcinoma 1Recurrence 1Melanoma 1Lymphoma, Follicular 1Lung Diseases 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Glioma 1Depressive Disorder, Major 1Breast Neoplasms 1Breast Neoplasm Female 1Bone Neoplasms 1Barrett Esophagus 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

Ipilimumab 114pembrolizumab 95Nivolumab 91aldesleukin 86Interleukin-2 57Cyclophosphamide 54Dacarbazine 52Vemurafenib 39trametinib 37Temozolomide 37incomplete Freund's adjuvant 35fludarabine phosphate 35sargramostim 32dabrafenib 32fludarabine 26Bevacizumab 26Paclitaxel 22MART-1 Antigen 21Granulocyte-Macrophage Colony-Stimulating Factor 21montanide ISA 51 20Interferon-alpha 20Cisplatin 20Carboplatin 19Sorafenib 18Introns 17Biopsy 17cobimetinib 16Radiosurgery 16atezolizumab 15Radiotherapy 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Melanoma × Diagnostic Imaging × Clear all
NCT04253574 2020-02-05

Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma

University of Basel

Completed
258 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡